☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Autoimmune diseases
Merck Entered into a WW Research Collaboration and License Agreement with Synthekine to Develop Novel Cytokine Therapeutics
November 2, 2021
Alvotech's AVT02 (a proposed biosimilar to Humira) Receives CHMP's Positive Opinion for the Treatment of Autoimmune Diseases
September 17, 2021
Merck to Acquire Pandion for ~$1.85B
February 26, 2021
Alvotech and DKSH Extend their Collaboration to Commercialize Six Biosimilars in Asia
September 22, 2020
Innovent's Sulinno (biosimilar- adalimumab) Receives NMPA's Approval for Autoimmune Diseases
September 4, 2020
Samsung Bioepis' Aybintio (SB8- biosimilar- bevacizumab) Receives the EC's Approval for Launch in EU
August 21, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.